medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2020, Number 07

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (07)

Factors associated with poor forecasting in pregnant women with SARS-Cov-2 diagnosis

Lira-Lucio JA, Roldán-Rodríguez E, Ochoa-Millán JG, Hernández-Escobar L, Padilla-Rivera CI, Ochoa-Gaitán G

Language: Spanish
References: 21
Page: 450-457
PDF size: 219.21 Kb.


ABSTRACT

Objective: To describe the associated factors with the degree of severity in pregnant Mexican women reported with SARS-CoV-2 virus infection.
Materials and Methods: Descriptive, transversal and comparative study of free dates reported by Mexico’s Health Secretary of COVID-19 patients until April 26th, 2020. Pregnant women positive to SARS-CoV-2 infection were included. Control group were women in reproductive age. Exclusion criteria were women with puerperal status reported as unknown or does not apply. Infection was analyzed by severity in both groups, then comorbidities associated to degree of severity were determined with descriptive statistic.
Results: 84 pregnant women were positive to SARS-CoV-2 vs 2,836 non-pregnant infected women in reproductive age. 33% of pregnant women required hospitalization vs 17% of control group. 2.4% vs 0.08% required intubation, 3.6% vs 1.3% were admitted to critical care unit and lethality was 7.14% vs 0.7% in pregnant vs control group respectively. Main comorbidities associated with severity in pregnant women were diabetes (50%) and tobacco use (33%).
Conclusion: Pregnant women have greater probability to develop a severe form of SAR-CoV-2 infection compared to women in reproductive age. The main associated factors to severe forms were diabetes and tobacco use.


REFERENCES

  1. David S, Ashley G. Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses 2020, 12, 194. doi:10.3390/v12020194.

  2. COVID-19 Map - Johns Hopkins Coronavirus Resource Center. Available from: https://coronavirus.jhu.edu/map.html.

  3. Latif P, et al. Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review. Arch Acad Emerg Med 2020;8(1):e34. Available from: https://www.ncbi.nlm. nih.gov/pmc/articles/PMC7092922/pdf/aaem-8-e34.pdf.

  4. Andreea AC, et al. Severity of 2009 Pandemic Influenza A (H1N1) Virus Infection in Pregnant Women. Obstet Gynecol 2010;115(4):717-26. doi: 10.1097/ AOG.0b013e3181d57947.

  5. Sonja AR, et al. Coronavirus Disease 2019 (COVID-19) and Pregnancy: What Obstetricians Need to Know. Am J Obstet Gynecol 2020; 222 (5): 415-26. doi: 10.1016/j. ajog.2020.02.017.

  6. William TS, et al. Severe ARDS in COVID-19-infected Pregnancy: Obstetric and Intensive Care Considerations. Am J Obstet Gynecol MFM 2020;14:100-120. doi: 10.1016/j. ajogmf.2020.100120.

  7. Chen H, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395(10226):809–15. doi: 10.1016/ S0140-6736(20)30360-3.

  8. Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–5069. doi: 10.1016/S0140- 6736(20)30183-5.

  9. Li Q, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199–1207. doi: 10.1056/NEJMoa2001316.

  10. Zhao, et al. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. Eur J Clin Microbiol Infect Dis 2020: 1-12.

  11. Datos abiertos de México. Información referente a casos COVID-19 en México. https://datos.gob.mx/busca/dataset/ informacion-referente-a-casos-covid-19-en-mexico

  12. Salud de la mujer. https://www.who.int/es/news-room/ fact-sheets/detail/women-s-health

  13. Rajesh T, et al. Mild or Moderate Covid-19. N Engl J Med 2020; 1-9. doi: 10.1056/NEJMcp2009249.

  14. RStudio Team. RStudio: Integrated Development Environment for R. Boston, MA 2015.

  15. Frank EH, Charles D. Harrell Miscellaneous, Package‘ Hmisc.’ GitHub 2020. https://github.com/harrelfe/ Hmisc

  16. Villanueva RAM, et al. ggplot2: Elegant Graphics for Data Analysis Using the Grammar of Graphics. New York: Springer-Verlag, 2016; 160-67. doi: 10.1080/15366367.2019.1565254.

  17. Kably A, et al. COVID-19 y sus repercusiones en la práctica ginecoobstetricia. Ginecol Obstet Mex. 2020; 88: 1-12. doi: 10.24245/gom.v88id.4129

  18. Tem p l eto n WL . E p i d em i c I nf l u en za . B r Med J 1941;1(4179):214. https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2161072/

  19. Chen D, et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int J Gynecol Obstet. 2020; 149 (2): 130-36. https://doi. org/10.1002/ijgo.13146

  20. Breindahl M, et al. Dilemmas and Priorities in the Neonatal Intensive Care Unit during the COVID-19 Pandemic. Dan Med J 2020;67(4). PMID: 32314729. https://pubmed.ncbi. nlm.nih.gov/32314729/

  21. Zhao S, et al. Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures. J Cardiothorac Vasc Anesth. 2020; 34 (5): 1125-31. https://doi. org/10.1053/j.jvca.2020.02.039




2020     |     www.medigraphic.com